The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patientsDUBSKY, P; BRASE, J. C; BACHNER, M et al.British journal of cancer. 2013, Vol 109, Num 12, pp 2959-2964, issn 0007-0920, 6 p.Article

Multidrug resistance-associated protein in acute myeloid leukemia : No impact on treatment outcomeFILIPITS, M; SUCHOMEL, R. W; ZÖCHBAUER, S et al.Clinical cancer research. 1997, Vol 3, Num 8, pp 1419-1425, issn 1078-0432Article

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancerZAGOURI, F; BAGO-HORVATH, Z; DIMOPOULOS, M.-A et al.British journal of cancer. 2013, Vol 108, Num 5, pp 1100-1105, issn 0007-0920, 6 p.Article

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus StatementAZIM, H. A; MICHIELS, S; LOI, S et al.Annals of oncology. 2013, Vol 24, Num 3, pp 647-654, issn 0923-7534, 8 p.Article

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cellsHODA, M. A; MÜNZKER, J; SETINEK, U et al.British journal of cancer. 2012, Vol 107, Num 12, pp 1978-1986, issn 0007-0920, 9 p.Article

Expression of the lung resistance protein predicts poor outcome in patients with multiple myelomaFILIPITS, M; DRACH, J; LUDWIG, H et al.Clinical cancer research. 1999, Vol 5, Num 9, pp 2426-2430, issn 1078-0432Article

Expression of the lung resistance protein (LRP) in primary breast cancerPOHL, G; FILIPITS, M; SUCHOMEL, R. W et al.Anticancer research. 1999, Vol 19, Num 6B, pp 5051-5055, issn 0250-7005Conference Paper

Immunocytochemical detection of the multidrug resistance-associated protein and p-glycoprotein in acute myeloid leukemia : impact of antibodies, sample source and disease status : Phenotypic and genotypic analyses of multidrug resistance (MDR) in clinical hospital practiceFILIPITS, M; SUCHOMEL, R. W; LECHNER, K et al.Leukemia. 1997, Vol 11, Num 7, pp 1073-1077, issn 0887-6924Article

Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesotheliomaGHANIM, B; HODA, M. A; SAMARZIJA, M et al.British journal of cancer. 2014, Vol 110, Num 4, pp 984-990, issn 0007-0920, 7 p.Article

Expression of p21^Wafl/Cip1, p57^Kip2 and HER2/neu in patients with gallbladder cancerPUHALLA, H; WRBA, F; KANDIOLER, D et al.Anticancer research. 2007, Vol 27, Num 3B, pp 1679-1684, issn 0250-7005, 6 p.Article

Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritisWOLF, J; STRANZL, T; FILIPITS, M et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 4, pp 564-568, issn 0003-4967, 5 p.Article

p53 analysis in gallbladder cancer: Comparison of gene analysis versus immunohistochemistryPUHALLA, H; KANDIOLER, D; LUDWIG, C et al.Anticancer research. 2004, Vol 24, Num 2C, pp 1201-1206, issn 0250-7005, 6 p.Article

Expression of folylpolyglutamyl synthetase predicts poor response to methotrexate therapy in patients with rheumatoid arthritisSTRANZL, T; WOLF, J; LEEB, B. F et al.Clinical and experimental rheumatology (Testo stampato). 2003, Vol 21, Num 1, pp 27-32, issn 0392-856X, 6 p.Article

Expression of the multidrug resistance protein (MRP1) in breast cancerFILIPITS, M; MALAYERI, R; SUCHOMEL, R. W et al.Anticancer research. 1999, Vol 19, Num 6B, pp 5043-5049, issn 0250-7005Conference Paper

Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemiaFILIPITS, M; POHL, G; STRANZL, T et al.Blood. 1998, Vol 91, Num 5, pp 1508-1513, issn 0006-4971Article

Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomasFILIPITS, M; SUCHOMEL, R. W; DEKAN, G et al.British journal of cancer. 1997, Vol 75, Num 2, pp 208-212, issn 0007-0920Article

Clinical relevance of drug resistance genes in malignant diseasesFILIPITS, M; SUCHOMEL, R. W; ZÖCHBAUER, S et al.Leukemia. 1996, Vol 10, pp S10-S17, issn 0887-6924, SUP3Conference Paper